Hybrid Biotech-Medtech Model
Definition
Framework that a company combining drug-like clinical trials with a device delivery mechanism has a cost and growth profile that shifts from biotech-style discovery spending to medtech-style organic expansion once the mechanism is established.
Cast within
No topic-region cast yet — this appears once Hybrid Biotech-Medtech Model's compiled claims are aligned into a topic region's argument tree.
Claims mentioning Hybrid Biotech-Medtech Model (3)
Your notes
Loading notes...